The wholesale unit, which will be based in New York and maintain a London underwriting facility, will focus on risks in the life sciences, high tech, financial institutions, health care and renewable energy sectors, Gallagher Associates said in a statement.
Its first insurance product for foreign clinical trials streamlines coverage in more than 100 countries.
Mark Bradway has been named director of the new unit. Mr. Bradway is a veteran of the wholesale market, having started his career as wholesale insurance broker Swett & Crawford Group Inc. in Los Angeles specializing in professional and management liability products for the financial services industry.